$1.89B Metabolomics Services Industry Forecast, 2028 – Increasing Adoption of Metabolomics and Investments by Market Players – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Metabolomics Services Market Forecast to 2028 – COVID-19 Impact and Global Analysis” report has been added to ResearchAndMarkets.com’s offering.

The global metabolomics services market is expected to reach US$ 1,895.14 million by 2028 from US$ 501.24 million in 2021; it is estimated to grow at a CAGR of 20.9% during 2021-2028.

The emerging markets in regions such as the Middle East, Africa, and Asia Pacific are creating significant opportunities for the key market players to expand their businesses. The majority of players concentrate on developing markets, such as India and China, owing to the huge populations, including a large number of people suffering from chronic diseases. With the rising production costs, healthcare companies are striving to produce sufficient revenues to meet the demands of their investors.

Consumer expectations from diagnostic processes are growing with advancements in biotechnology. Moreover, these developments are encouraging the introduction of more analytical systems and facilitating the shift toward personalized medicine. Infectious disease testing, molecular oncology, and pharmacogenomics are among the high-potential segments in emerging countries. Various players in the industry have been investing significant shares of their revenues in R&D activities to develop better and advanced products and technologies for the healthcare sector.

The Asia Pacific metabolomics services market is expected to grow at the fastest CAGR during the forecast period due to the presence of significant biopharmaceutical companies in countries such as Japan and the growing number of local companies in countries such as China and India. Further, the growing prevalence of cancer and other chronic diseases is likely to boost the market growth in the coming years.

The global metabolomics services market, based on service type, has been segmented into targeted metabolomics service, and untargeted metabolomics service. The targeted metabolomics service segment is likely to hold the largest share of the market in 2021. Moreover, the targeted metabolomics service segment is anticipated to register the highest CAGR in the market during the forecast period, due to their incumbent usage, high volume consumption, and product innovation.

The global metabolomics services market, based on application is segmented into pharmaceutical and biotechnology industry, agritech, environment. In 2021, the pharmaceutical and biotechnology industry segment is likely to hold the largest share of the market. Moreover, the segment is also expected to witness growth in its demand at a fastest CAGR of 21.6% during 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions across the globe.

Key Topics Covered

1. Introduction

1.1 Scope of the Study

1.2 Research Report Guidance

1.3 Market Segmentation

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Metabolomics Services Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Experts Opinion

5. Metabolomics Services Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidences of Cancer

5.1.2 Increasing Adoption of Metabolomics and Investments by Market Players

5.2 Market Restraints

5.2.1 High Cost of Tools, Instruments, and Usage

5.3 Market Opportunities

5.3.1 Development Opportunities in Emerging Countries

5.4 Future Trends

5.4.1 Use of Artificial Intelligence (AI) and Biomarkers in Biomarker-related Analysis and Personalized Therapy

5.5 Impact Analysis

5.6 Opportunities for Contract Research (CR)

5.7 Opportunities for Supplies of Consumables

5.8 Opportunities for Commercialization of Disease Biomarkers

6. Metabolomics Services Market – Global Analysis

6.1 Global Metabolomics Services Market Revenue Forecast and Analysis

6.2 Global Metabolomics Services Market, By Geography – Forecast and Analysis

6.3 Market Positioning of Key Players

7. Global Metabolomics Services Market Revenue and Forecasts to 2028 – by Service Type

7.1 Overview

7.2 Global Metabolomics Services Market, by Service Type 2021 & 2028 (%)

7.3 Targeted Metabolomics Service

7.4 Untargeted Metabolomics Service

8. Metabolomics Services Market Revenue and Forecasts to 2028 – Application

8.1 Overview

8.2 Global Metabolomics Services Market Share, by Application 2021 & 2028 (%)

8.3 Pharmaceutical and Biotechnology Industry

8.4 Agritech

8.5 Environment

9. Metabolomics Services Market Revenue and Forecasts to 2028 – Geographical Analysis

9.1 North America: Metabolomics Services Market

9.2 Europe: Metabolomics Services Market

9.3 Asia Pacific Metabolomics Services Market Revenue and Forecasts to 2028

9.4 Middle East & Africa Metabolomics Services Market Revenue and Forecasts to 2028

9.5 South and Central America Metabolomics Services Market Revenue and Forecasts to 2028

10. Impact of COVID-19 Pandemic on Metabolomics Services Market

10.1 North America: Impact Assessment of COVID-19 Pandemic

10.2 Europe: Impact Assessment of COVID-19 Pandemic

10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Metabolomics Services Market – Industry Landscape

11.1 Overview

11.2 Growth Strategies Done by the Companies in the Market, (%)

11.3 Organic Developments

11.4 Inorganic Developments

12. Company Profiles

12.1 BASF SE

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 TMIC

12.3 Creative Proteomics

12.4 BGI

12.5 RTI International

12.6 Afekta Technologies Ltd.

12.7 Fred Hutchinson Cancer Research Center

12.8 West Coast Metabolomics Center

12.9 Molecular You

12.10 Metabolon, Inc.

12.11 Biocrates Life Sciences AG

12.12 Chenomx Inc.

12.13 C-CAMP

12.14 metaSysX

12.15 MS-Omics

For more information about this report visit https://www.researchandmarkets.com/r/iaa0xa

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900